A Phase 1 Trial to Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of MBX-400 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Filociclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions
- 21 Dec 2017 Status changed from discontinued to completed.
- 02 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 02 Jun 2015 New trial record